DK1091734T3 - Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde - Google Patents

Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde

Info

Publication number
DK1091734T3
DK1091734T3 DK99930683T DK99930683T DK1091734T3 DK 1091734 T3 DK1091734 T3 DK 1091734T3 DK 99930683 T DK99930683 T DK 99930683T DK 99930683 T DK99930683 T DK 99930683T DK 1091734 T3 DK1091734 T3 DK 1091734T3
Authority
DK
Denmark
Prior art keywords
mucosa
reducing
radiation therapy
harmful effects
animal skin
Prior art date
Application number
DK99930683T
Other languages
Danish (da)
English (en)
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK1091734T3 publication Critical patent/DK1091734T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK99930683T 1998-06-29 1999-06-24 Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde DK1091734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (fr) 1998-06-29 1999-06-24 Technique permettant d'attenuer les lesions cutanees et muqueuses provoquees par la radiotherapie chez un animal

Publications (1)

Publication Number Publication Date
DK1091734T3 true DK1091734T3 (da) 2004-01-26

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99930683T DK1091734T3 (da) 1998-06-29 1999-06-24 Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde

Country Status (17)

Country Link
US (1) US6015798A (fr)
EP (1) EP1091734B1 (fr)
JP (2) JP4860814B2 (fr)
AR (1) AR019728A1 (fr)
AT (1) ATE249821T1 (fr)
AU (1) AU761266B2 (fr)
BR (1) BR9911663A (fr)
CA (1) CA2336628C (fr)
DE (1) DE69911409T2 (fr)
DK (1) DK1091734T3 (fr)
ES (1) ES2207951T3 (fr)
MX (1) MXPA01000152A (fr)
NO (1) NO329910B1 (fr)
NZ (1) NZ508766A (fr)
TR (1) TR200100457T2 (fr)
WO (1) WO2000000189A1 (fr)
ZA (1) ZA200007650B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
ATE512594T1 (de) * 1999-09-09 2011-07-15 Nestle Sa Verbesserung des zustandes älterer haustiere
ES2284644T3 (es) * 2000-05-01 2007-11-16 The Iams Company Composicion alimenticia para animales de compañia para reducir la respuesta inflamatoria en gatos.
AU2001265273B2 (en) 2000-06-01 2006-11-23 Jbs United, Inc. Animal food and method
EP1350435B1 (fr) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions et méthodes pour augmenter l'assimilation des lipides dans les animaux de compagnie
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
GB2414916A (en) * 2002-12-23 2005-12-14 Mars Uk Ltd Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
ATE402695T1 (de) * 2003-08-11 2008-08-15 Hills Pet Nutrition Inc Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
EP2324828A1 (fr) * 2003-08-18 2011-05-25 BTG International Limited Traitement de maladies neurodégénératives
ES2525729T3 (es) 2003-11-25 2014-12-29 Virginia Tech Intellectual Properties, Inc. Composición para consumo animal para su uso en la reducción de la actividad MAP cinasa
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
CN101150962A (zh) 2004-12-30 2008-03-26 希尔氏宠物营养品公司 提高幼年动物生活质量的方法
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
WO2009070589A1 (fr) * 2007-11-30 2009-06-04 Jbs United, Inc. Procédé et composition pour traiter une hémorragie pulmonaire
JP6001184B2 (ja) * 2012-11-15 2016-10-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 食餌のミネラル制限を介したヘアボール制御
CA3052047A1 (fr) 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Compositions therapeutiques anti-pathogenes
MX2021003810A (es) 2018-10-01 2021-07-06 Wintermute Biomedical Inc Composiciones terapeuticas.
AU2019478729B2 (en) * 2019-12-19 2024-08-29 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions
AU2019479288B2 (en) 2019-12-19 2024-04-18 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety
WO2022087203A1 (fr) * 2020-10-21 2022-04-28 Hill's Pet Nutrition, Inc. Compositions alimentaires pour animaux de compagnie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (fr) * 1985-09-12 1991-07-02 Robert J. Smith Methode de traitement de troubles cataboliques
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (fr) * 1994-04-18 1995-10-19 Gregory A. Reinhart Nourriture pour animaux de compagnie, renfermant des acides gras omega-6 et omega-3, et methode pour attenuer les reactions inflammatoires de la peau
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Also Published As

Publication number Publication date
AU761266B2 (en) 2003-05-29
NO20006575L (no) 2001-02-28
NO329910B1 (no) 2011-01-24
ZA200007650B (en) 2002-08-28
TR200100457T2 (tr) 2001-08-21
CA2336628C (fr) 2009-03-24
JP5704791B2 (ja) 2015-04-22
NZ508766A (en) 2003-05-30
AU4716799A (en) 2000-01-17
NO20006575D0 (no) 2000-12-21
DE69911409T2 (de) 2004-07-08
EP1091734B1 (fr) 2003-09-17
MXPA01000152A (es) 2002-10-17
AR019728A1 (es) 2002-03-13
JP2002519320A (ja) 2002-07-02
WO2000000189A1 (fr) 2000-01-06
EP1091734A1 (fr) 2001-04-18
JP2009035533A (ja) 2009-02-19
US6015798A (en) 2000-01-18
ES2207951T3 (es) 2004-06-01
CA2336628A1 (fr) 2000-01-06
ATE249821T1 (de) 2003-10-15
DE69911409D1 (de) 2003-10-23
JP4860814B2 (ja) 2012-01-25
BR9911663A (pt) 2005-12-20

Similar Documents

Publication Publication Date Title
NO20006575D0 (no) Fremgangsmåte for å redusere skadelige effekter av stråleterapi på hud og slimhinner hos dyr
GB0118394D0 (en) Radiation treatment system and method
DK0881881T3 (da) Antiparasitært præparat til behandling og beskyttelse af kæledyr
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
EP1065978A4 (fr) Dispositif therapeutique implantable et methode afferente
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
NO20000996L (no) Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel
IS5525A (is) Innúðabúnaður og aðferð
DK1450891T3 (da) Afgivelsessystem til interstitiel stråleterapi og fremgangsmåde til fremstilling deraf
KR960008976A (ko) 처리장치 및 처리방법
DE69800707D1 (de) Laserbehandlungsvorrichtung
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
DE69812725D1 (de) Laserbehandlungsgerät
NO991701D0 (no) HIV og cancer behandling
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
DK0961609T3 (da) Fremgangsmåde til forbedring af sundhedstilstanden af hår og hovedbund
FI951060A7 (fi) Formulaatioita ja hoitomenetelmiä
DE69907803D1 (de) Laserbehandlungsgerät
DE60216970D1 (de) Implantierbare herzstimulationsvorrichtung sowie diese vorrichtung enthaltendes system
DE69828985D1 (de) Lichtgebender katheter sowie anwendungsverfahren
ID27483A (id) Metoda terapi gen
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE69937907D1 (de) Sprachkodiererprozessor und sprachkodierungsmethode
BR9507555A (pt) Agente de tratamento de pele térmico
IT1313366B1 (it) Apparecchio e procedimento per allineare componenti